Báo cáo khoa học: " Inactivation of respiratory syncytial virus by zinc finger reactive compounds"

Inactivation of respiratory syncytial virus by zinc finger reactive compounds | Boukhvalova et al. Virology Journal 2010 7 20 http content 7 1 20 VIROLOGY JOURNAL RESEARCH Open Access Inactivation of respiratory syncytial virus by zinc finger reactive compounds Marina S Boukhvalova Gregory A Prince Jorge CG Blanco Abstract Background Infectivity of retroviruses such as HIV-1 and MuLV can be abrogated by compounds targeting zinc finger motif in viral nucleocapsid protein NC involved in controlling the processivity of reverse transcription and virus infectivity. Although a member of a different viral family Pneumoviridae respiratory syncytial virus RSV contains a zinc finger protein M2-1 also involved in control of viral polymerase processivity. Given the functional similarity between the two proteins it was possible that zinc finger-reactive compounds inactivating retroviruses would have a similar effect against RSV by targeting RSV M2-1 protein. Moreover inactivation of RSV through modification of an internal protein could yield a safer whole virus vaccine than that produced by RSV inactivation with formalin which modifies surface proteins. Results Three compounds were evaluated for their ability to reduce RSV infectivity 2 2 -dithiodipyridine AT-2 tetraethylthiuram disulfide and tetramethylthiuram disulfide. All three were capable of inactivating RSV with AT-2 being the most potent. The mechanism of action of AT-2 was analyzed and it was found that AT-2 treatment indeed results in the modification of RSV M2-1. Altered intramolecular disulfide bond formation in M2-1 protein of AT-2-treated RSV virions might have been responsible for abrogation of RSV infectivity. AT-2-inactivated RSV was found to be moderately immunogenic in the cotton rats and did not cause a vaccine-enhancement seen in animals vaccinated with formalin-inactivated RSV. Increasing immunogenicity of AT-2-inactivated RSV by adjuvant Ribi however led to vaccine-enhanced disease. Conclusions This work presents evidence that compounds that inactivate .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.